Sage Targets June Launch as FDA Approves Postpartum Drug

The following video is brought to you courtesy of the Health News YouTube Channel. Click the video below to watch it now.

Mar.21 — Jeff Jonas, chief executive officer at Sage Therapeutics, discusses Food and Drug Administration approval of the company’s first postpartum drug, the price of the drug, and products in their drug pipeline. He speaks with Bloomberg’s Taylor Riggs on “Bloomberg Surveillance.”

Comments are closed.